| id | C00023868 |
|---|---|
| Name | Ganodermadiol / 5alpha-Lanosta-7,9(11),24-triene-3beta,26-one |
| CAS RN | 104700-96-1 |
| Standard InChI | InChI=1S/C30H48O2/c1-20(19-31)9-8-10-21(2)22-13-17-30(7)24-11-12-25-27(3,4)26(32)15-16-28(25,5)23(24)14-18-29(22,30)6/h9,11,14,21-22,25-26,31-32H,8,10,12-13,15-19H2,1-7H3/b20-9+/t21-,22-,25+,26+,28-,29-,30+/m1/s1 |
| Standard InChI (Main Layer) | InChI=1S/C30H48O2/c1-20(19-31)9-8-10-21(2)22-13-17-30(7)24-11-12-25-27(3,4)26(32)15-16-28(25,5)23(24)14-18-29(22,30)6/h9,11,14,21-22,25-26,31-32H,8,10,12-13,15-19H2,1-7H3 |
| Phytochemical cluster | |
|---|---|
| KCF-S cluster | No. 91 |
| By standard InChI | CHEMBL240972 |
|---|---|
| By standard InChI Main Layer | CHEMBL240972 |
| By LinkDB |
|---|
| By CAS RN | C050246 |
|---|
| class name | count |
|---|
| family name | count |
|---|---|
| Ganodermataceae | 3 |
| KNApSAcK organism | *ID | *family | *plant class | *kingdom |
|---|---|---|---|---|
| Ganoderma concinna | 5314 | Ganodermataceae | Fungi | |
| Ganoderma lucidum | 5315 | Ganodermataceae | Fungi | |
| Ganoderma pfeiferri | 5314 | Ganodermataceae | Fungi |
| accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|---|
| P06276 | Cholinesterase | Hydrolase | CHEMBL240972 |
CHEMBL1918467
(1)
|
0 / 0 |
| P22303 | Acetylcholinesterase | Hydrolase | CHEMBL240972 |
CHEMBL1918466
(1)
|
1 / 0 |
| P10275 | Androgen receptor | NR3C4 | CHEMBL240972 |
CHEMBL887928
(1)
|
3 / 4 |
| OMIM | preferred title | UniProt |
|---|---|---|
| #300068 | Androgen insensitivity syndrome; ais |
P10275
|
| #312300 | Androgen insensitivity, partial; pais |
P10275
|
| #313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
| #112100 | Yt blood group antigen |
P22303
|
| KEGG | disease name | UniProt |
|---|---|---|
| H00024 | Prostate cancer |
P10275
(related)
|
| H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
| H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
| H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|